Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

RG 3487

Next Previous
X
Search
Drug Profile

RG 3487

Alternative Names: MEM3454; R1589; R3487; RG3487; RO5313534

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Memory Pharmaceuticals; Roche
  • Developer Roche
  • Class Antidementias; Antipsychotics; Small molecules
  • Mechanism of Action Alpha7 nicotinic acetylcholine receptor agonists; Serotonin 3 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Schizophrenia
  • Discontinued Alzheimer's disease

Most Recent Events

  • 13 Nov 2010 Preclinical pharmacodynamics data presented at the 40th Annual Meeting of the Society for Neuroscience (SFN-2010)
  • 21 Oct 2009 Pharmacodynamics & pharmacokinetics data from preclinical trials in Alzheimer's disease presented at the 39th Annual Meeting of the Society for Neuroscience (SfN-2009)
  • 24 Dec 2008 Memory initiates enrolment in a phase II trial for Schizophrenia in USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top